Everest Medicines Limited (HKG:1952)

Hong Kong · Delayed Price · Currency is HKD

38.20

+3.52 (10.15%)

At close: Mar 27, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Pharmaceutical Products	706.68M	125.93M	12.79M	54.00K
Pharmaceutical Products Growth	461.16%	884.46%	23588.89%	-
Total	706.68M	125.93M	12.79M	54.00K
Total Growth	461.16%	884.46%	23588.89%	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Mainland China	706.68M	125.93M	12.79M	54.00K
Mainland China Growth	461.16%	884.46%	23588.89%	-
Total	706.68M	125.93M	12.79M	54.00K
Total Growth	461.16%	884.46%	23588.89%	-

Source: S&P Global Market Intelligence.